Obinutuzumab for previously untreated chronic lymphocytic leukemia

被引：2
|
作者：
不详
机构：
来源：
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY | 2014年 / 12卷 / 04期
关键词：
D O I：
10.12788/jcso.0032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：118 / 120
页数：3
相关论文
共 50 条
  • [1] Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia
    Gay, Nathan D.
    Kozin, Eliana
    Okada, Craig
    Danilov, Alexey V.
    Spurgeon, Stephen
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2258 - 2260
  • [2] Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
    Hill, Brian T.
    Kalaycio, Matt
    ONCOTARGETS AND THERAPY, 2015, 8 : 2391 - 2397
  • [3] COST-EFFECTIVENESS OF OBINUTUZUMAB IN PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
    Reyes, C.
    Gazauskas, G.
    Veentra, D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [4] Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective
    Owen, Carolyn J.
    Stewart, Douglas A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (04) : 161 - 170
  • [5] IS OBINUTUZUMAB COST-EFFECTIVE FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA IN THE UNITED STATES?
    Reyes, C.
    Veenstra, D.
    Ramsey, S.
    HAEMATOLOGICA, 2014, 99 : 488 - 488
  • [6] Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia
    Byrd, John C.
    Flynn, Joseph M.
    Kipps, Thomas J.
    Boxer, Michael
    Kolibaba, Kathryn S.
    Carlile, David J.
    Fingerle-Rowson, Guenter
    Tyson, Nicola
    Hirata, Jamie
    Sharman, Jeff P.
    BLOOD, 2016, 127 (01) : 79 - 86
  • [7] Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil
    Tam, Constantine
    Kuss, Bryone
    Opat, Stephen
    Boulos, Joy
    Marlton, Paula
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 5 - 10
  • [8] PHARMACOECONOMIC ANALISYS OF OBINUTUZUMAB PLUS CHLORAMBUCIL IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA AND COEXISTING CONDITIONS
    Kolbin, A.
    Vilum, I
    Balykina, Y.
    Proskurin, M.
    VALUE IN HEALTH, 2017, 20 (09) : A438 - A438
  • [9] Cost-Effectiveness Analysis of Obinutuzumab Versus Ofatumumab for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Reyes, Carolina
    Gazauskas, Gregory
    Becker, Ursula
    Moreno, Santiago
    Veenstra, David L.
    BLOOD, 2014, 124 (21)
  • [10] Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Previously Untreated Chronic Lymphocytic Leukemia
    Shah, Arpita
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (10) : 1356 - 1361
12345